Navigation Links
Blindness may be genetic by nature

Your kind of immunity may lead you to blindness. According to a new research to be published in the Science journal, //scientists had been able to find out a genetic component that may lead to loss of sight.

In search of what is commonly known as blindness due to age, scientists have come up with a gene that may cause macular degeneration in elderly people. This is a variety of gene that encodes a protein called complement factor H (CFH). as people grow old, there happens very small damages to the eye tissue. Often there forms a combination of fats, proteins etc called drusen that affects the eye tissue s well. The particular variant of gene CFH causes up to seven times damage to eye tissue in elderly when compared to other forms of the gene. This happens, as this particular form of genes does not inhibit inflammations in the eye, causing loss of vision.

Three studies, conducted at different places, have come up with the same gene causing geriatric macular degeneration. One study even suggests that the gene may be responsible for almost half of the cases of blindness that happens to the elderly population.

http://www.sciencemag.org/cgi/content/abstract/1110189
'"/>




Page: 1

Related medicine news :

1. Blindness can be stopped with drug for acne treatment
2. Smoking Linked to Blindness
3. Enzyme Responsible For Congenital Blindness
4. Millions Of Diabetic And Glaucoma Patients Risk Blindness
5. Avastin, anti-Cancer Drug leads to Blindness and Other Complications
6. Genes That Were Responsible For The Cause Of Blindness Identified
7. Investigations Reveal That Infections Due To Contact lens Could Cause Blindness
8. Research into Blindness Cure Goes Digital
9. River Blindness Incidence Reduced With Effective Treatment
10. Blindness And Trachoma
11. Blindness cases in China on the rise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: